Most Read Articles
6 days ago
The aromatase inhibitor anastrozole shows promise in the treatment of children with congenital adrenal hyperplasia, reducing bone age advancement without adversely affecting bone mineral density and visceral adipose tissue, as shown in a recent study.
5 days ago
The choice between nonvitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) for stroke prevention appears to be complex and largely heterogenous across different, countries, a new study has found.
13 Jun 2019
Response to desmopressin treatment for nocturnal enuresis in children appears to be compromised in the presence of constipation, particularly in children with severe enuresis and those prescribed low doses, as reported in a recent study.
14 Jun 2019
Elevated serum urate concentrations may be protective against dementia, regardless of subtype, reports a recent study.

Nerve growth factor tied to overactive bladder symptoms in patients with benign prostatic hyperplasia

12 Sep 2018

An association exists between nerve growth factor and overactive bladder symptoms in patients with benign prostatic hyperplasia, according to a study. Nerve growth factor also correlates with the assessment of successful long-term treatment outcome of bladder outlet obstruction with symptoms of overactive bladder.

This prospective study included 1,778 patients with benign prostatic hyperplasia at Peking University People’s Hospital between January 2011 and January 2013. A commercial enzyme-linked immunosorbent assay kit was used to determine urinary nerve growth factor levels preoperatively.

The investigators determined prostate volume, International Prostate Symptom Score (I-PSS), quality of life, Overactive Bladder Symptom Score (OABSS), ultrasound estimated postvoid residual urine and urodynamics before surgery. I-PSS, OABSS and urinary nerve growth factor levels were evaluated again 1 year after transurethral prostate resection.

Patients with moderate and severe lower urinary tract symptoms had varying urinary nerve growth factor/creatinine levels (mean, 10.513±4.255 vs 12.334±4.048 pg/μmol; p=0.002).

Although no significant difference was seen between patients with grades III/IV and V/VI bladder outlet obstruction (mean, 11.285±4.069 vs 11.781±4.437 pg/μmol; p=0.354), there were significant differences in urinary nerve growth factor/creatinine levels in patients without overactive bladder (mean, 8.132±3.489 pg/μmol), and mild, moderate and severe overactive bladder (mean, 10.128±3.817, 13.232±3.290 and 14.029±3.820 pg/μmol, respectively; p<0.001).

Compared with baseline, mean urinary nerve growth factor/creatinine (8.978±4.022 pg/μmol; p<0.001), and I-PSS and OABSS (10.2±5.4 and 4.3±3.7, respectively; p<0.001 for each) decreased 1 year after transurethral prostate resection.

Moreover, the fair/poor vs the good outcome group had higher mean baseline urinary nerve growth factor/creatinine (12.319±4.017 vs 11.015±4.298 pg/μmol; p=0.045), higher mean 1-year urinary nerve growth factor/creatinine (10.847±4.267 vs 7.850±3.419 pg/μmol; p<0.001) and a lesser mean postoperative change in urinary nerve growth factor/creatinine (1.472±4.928 vs 3.165±4.863 pg/μmol; p=0.031).

Editor's Recommendations
Most Read Articles
6 days ago
The aromatase inhibitor anastrozole shows promise in the treatment of children with congenital adrenal hyperplasia, reducing bone age advancement without adversely affecting bone mineral density and visceral adipose tissue, as shown in a recent study.
5 days ago
The choice between nonvitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) for stroke prevention appears to be complex and largely heterogenous across different, countries, a new study has found.
13 Jun 2019
Response to desmopressin treatment for nocturnal enuresis in children appears to be compromised in the presence of constipation, particularly in children with severe enuresis and those prescribed low doses, as reported in a recent study.
14 Jun 2019
Elevated serum urate concentrations may be protective against dementia, regardless of subtype, reports a recent study.